Nephros, Inc. (NEPH) DCF Valuation

Nephros, Inc. (Neph) DCF Valoración

US | Healthcare | Medical - Instruments & Supplies | NASDAQ
Nephros, Inc. (NEPH) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Nephros, Inc. (NEPH) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Simplifique la valoración de Nephros, Inc. (NEPH) con esta calculadora DCF personalizable! Con Real Nephros, Inc. (NEPH) financieros y entradas de pronóstico ajustables, puede probar escenarios y descubrir el valor razonable de Nephros, Inc. (NEPH) en minutos.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 10.3 8.6 10.4 10.0 14.2 15.8 17.5 19.3 21.4 23.7
Revenue Growth, % 0 -17.16 21.53 -4.12 42.74 10.75 10.75 10.75 10.75 10.75
EBITDA -3.0 -3.9 -2.2 -3.9 -1.4 -4.6 -5.1 -5.6 -6.2 -6.9
EBITDA, % -29.12 -45.99 -21.43 -39.16 -9.69 -29.08 -29.08 -29.08 -29.08 -29.08
Depreciation .2 .5 .5 .6 .2 .6 .7 .8 .8 .9
Depreciation, % 1.94 5.6 4.93 5.72 1.5 3.94 3.94 3.94 3.94 3.94
EBIT -3.2 -4.4 -2.7 -4.5 -1.6 -5.2 -5.8 -6.4 -7.1 -7.8
EBIT, % -31.05 -51.58 -26.36 -44.88 -11.19 -33.01 -33.01 -33.01 -33.01 -33.01
Total Cash 4.2 8.2 7.0 3.6 4.3 8.5 9.4 10.5 11.6 12.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 1.3 1.4 1.6 1.3 1.5
Account Receivables, % 12.29 15.93 15.77 12.89 10.51
Inventories 2.6 5.3 4.8 3.2 2.5 5.7 6.3 7.0 7.8 8.6
Inventories, % 24.79 61.96 46.09 31.61 17.35 36.36 36.36 36.36 36.36 36.36
Accounts Payable 1.0 .4 1.3 .7 .9 1.3 1.4 1.6 1.7 1.9
Accounts Payable, % 9.28 4.94 12.82 7.42 6.13 8.12 8.12 8.12 8.12 8.12
Capital Expenditure .0 -.2 .0 -.1 -.1 -.2 -.2 -.2 -.2 -.2
Capital Expenditure, % -0.13548 -2.79 -0.34602 -1.37 -0.52676 -1.03 -1.03 -1.03 -1.03 -1.03
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -3.0 -4.6 -3.0 -7.7 -1.6 -5.1 -5.7 -6.3 -7.0 -7.7
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -5.7 -7.7 -1.3 -5.8 -.8 -8.2 -5.9 -6.5 -7.2 -8.0
WACC, % 9.45 9.48 9.48 9.48 9.48 9.48 9.48 9.48 9.48 9.48
PV UFCF
SUM PV UFCF -27.5
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -8
Terminal Value -109
Present Terminal Value -69
Enterprise Value -97
Net Debt -2
Equity Value -94
Diluted Shares Outstanding, MM 10
Equity Value Per Share -9.09

What You Will Get

  • Comprehensive NEPH Financials: Access to historical and forecasted data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures to fit your analysis.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Explore various scenarios to assess Nephros, Inc.'s future performance.
  • User-Friendly Interface: Designed for industry professionals while remaining accessible to newcomers.

Key Features

  • Customizable Financial Inputs: Adjust essential metrics such as revenue projections, profit margins, and operational costs.
  • Instant DCF Analysis: Automatically computes intrinsic value, net present value, and additional financial metrics.
  • High-Precision Valuation: Incorporates Nephros, Inc.'s (NEPH) actual financial data for accurate valuation results.
  • Simplified Scenario Testing: Easily evaluate various scenarios and analyze their potential impacts.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Nephros, Inc. (NEPH) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures specific to Nephros, Inc. (NEPH).
  • 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV for Nephros, Inc. (NEPH).
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation outcomes for Nephros, Inc. (NEPH).
  • 5. Present with Assurance: Deliver professional valuation insights to bolster your decision-making for Nephros, Inc. (NEPH).

Why Choose This Calculator for Nephros, Inc. (NEPH)?

  • Designed for Experts: A sophisticated tool utilized by financial analysts, investment managers, and industry consultants.
  • Accurate Data: Nephros’ historical and projected financials are preloaded for precise calculations.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Step-by-step guidance ensures a smooth calculation experience.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for analyzing Nephros, Inc. (NEPH).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the healthcare sector.
  • Consultants and Advisors: Offer clients precise valuation insights for Nephros, Inc. (NEPH) investments.
  • Students and Educators: Utilize real-world data to learn and teach financial modeling in the healthcare industry.
  • Medical Technology Enthusiasts: Gain insights into how companies like Nephros, Inc. (NEPH) are valued in the market.

What the Template Contains

  • Pre-Filled DCF Model: Nephros, Inc.'s (NEPH) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Nephros, Inc.'s (NEPH) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.